Looking For an OpenSpecimen Alternative?

One configurable system for sample tracking, experiment data, and full traceability

Prepared by Tori Highley

OpenSpecimen works well for academic medical centers and cancer research biobanks where managing human biospecimens through defined collection protocols is the core workflow. For labs that also need experiment documentation, assay data management, and instrument data capture in the same system as their samples, it doesn’t extend that far. That gap is where biorepositories and research labs start looking for an OpenSpecimen alternative.

OpenSpecimen vs. Labkey LIMS

 

	OpenSpecimen	LabKey LIMS
Overview	LIMS for specimen collection, consent, and distribution. Purpose-built for human biospecimen workflows.	A configurable laboratory information management system for sample tracking, experiment documentation, assay management, and instrument data capture, frequently configured to biospecimen and biobank applications.
Best for	Academic medical centers and standalone biobanks managing human biospecimens with consent requirements and specimen distribution workflows, without a need to track deeper experimental or instrument data.	Research labs and biorepositories that need sample tracking integrated with experiment documentation, assay results, and instrument data in one system configured to their specific use case.
Key strengths	Longitudinal collection protocols with defined timepoints Consent collection and participant tracking Specimen request and distribution workflows REDCap, Epic, and Cerner integration options Fixed unlimited-user licensing at institutional tier Support and implementation are add-ons	End-to-end sample tracking with full chain-of-custody audit trail Integrated ELN for experiment documentation linked directly to samples Configurable assay management with sample-assay linkage Instrument data capture via robust API and import pipelines No-code metadata and workflow configuration Cross-study data centralization with global search Price includes migration, implementation, and customer support
Considerations	Scope is specific to biobanking. Experiment documentation, assay data management, and instrument integration require separate systems or add-on investment. Each integration (REDCap, Epic, instruments) carries a five-digit one-time fee.	Requires configuration to match specific biobanking workflows. Clinical consent management and participant-centric data models are not native capabilities, but can have API and other connection-based integrations with Enterprise.
Compliance	Audit trail, role-based access control, consent documentation	Searchable and filterable audit trail with reason-for-change capture, role-based permissions, and timestamped action logs
Analytics and reporting	Pivot-table reporting and CSV export	Configurable data views, calculated columns, and REST API access for downstream analytics
Data integration	Clinical system integration via separately purchased plugins (REDCap, Epic, Cerner)	Instrument integration via API and file watchers; REST API for connections to external systems
Customization	Custom fields and forms configured by admin without coding	Metadata schemas, sample sources, notebook templates, workflow templates, specimen fields, and assay designs configured by admin without coding
Deployment	Krishagni-hosted cloud (US, EU, Australia), On-premise (institutional tier only)	Cloud-based in your region, On-premise allowed for Biologics LIMS (part of LabKey’s LIMS suite)
Bottom line	A strong choice for biobanks managing human biospecimens with clinical integration needs and consent-driven workflows.	A better fit for labs and biorepositories that need sample tracking connected to experiment documentation, assay data, and instrument output.

 

Why Labs Looking for an OpenSpecimen Alternative Would Choose Labkey LIMS

OpenSpecimen is well-regarded in biobanking for real reasons. Its collection protocol structure and consent tracking are purpose-built for academic biobanks. Organizations tracking human biospecimens through defined clinical timepoints get real value there.

The underlying software is free and open source under a BSD license, though OpenSpecimen managed deployment comes with a one time cost that grows if you have more than five users. Many teams also pair it with REDCap to unify specimen records with clinical data capture, an integration that carries a separately purchased one-time fee.

The scope is the limitation. OpenSpecimen is a specimen metadata system: it tracks the specimen, its annotations, and the protocols around collection and distribution. The data generated around those specimens after collection has to live somewhere else: assay results, flow cytometry output, genomic and proteomic records, instrument data. For a translational research center running all of that alongside a biobank, that means additional systems and the integration work to connect them.

No native experiment, assay, or instrument data management

Labs running translational research generate flow cytometry, genomics, proteomics, and other assay data alongside biospecimen collection. OpenSpecimen doesn’t manage this natively. Connecting it to specimen records requires a separate platform and an integration layer built between them. OpenSpecimen also has no electronic lab notebook component, so teams that need bench documentation linked to specimen records are running two separate systems from the start.

LabKey LIMS closes this gap. Sample tracking, experiment documentation, assay data, and instrument output live in the same configurable system, with one audit trail running across all of it. Every edit carries a reason for change, and data stays searchable and traceable across every study in the same repository.

 

 

 
 

Take a tour to see how LabKey LIMS connects sample tracking, experiment documentation, and data analysis in a single configurable system.

About the author
Tori Highley
Science and Research Writer
Tori Highley is a science and research writer specializing in scientific software and laboratory informatics. She holds a physics degree with theoretical research on monopole interactions in Bose-Einstein condensates, and previously worked at SPIE and on Spark Science, a podcast featuring researchers. At LabKey, she writes product content, customer case studies, and SEO/GEO strategy for software used by research and testing labs.